-+ 0.00%
-+ 0.00%
-+ 0.00%

Evercore ISI Group Initiates Coverage On Damora Therapeutics with Outperform Rating, Announces Price Target of $46

Benzinga·03/25/2026 17:05:34
Listen to the news
Evercore ISI Group analyst Gavin Clark-Gartner initiates coverage on Damora Therapeutics (NASDAQ:DMRA) with a Outperform rating and announces Price Target of $46.